Reducing Hospital-Acquired Infection by Quantitative Risk Modeling of Intravenous Bag Preparation

References

1. 1.↵
   1. Broderick A.,
   2. Mori M.,
   3. Nettleman M. D.,
   4. Streed S. A.,
   5. Wenzel R. P.

   Nosocomial infections: validation of surveillance and computer modeling to identify patients at risk. Am. J. Epidemiol. 1990, 131 (4), 734–742.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Morrison A. J. Jr.,
   2. Kaiser D. L.,
   3. Wenzel R. P.

   A measurement of the efficacy of nosocomial infection control using the 95 percent confidence interval for infection rates. Am. J. Epidemiol. 1987, 126 (2), 292–297.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Wenzel R. P.,
   2. Osterman C. A.,
   3. Townsend T. R.,
   4. Veazey J. M. Jr.,
   5. Servis K. H.,
   6. Miller L. S.

   Development of a statewide program for surveillance and reporting of hospital-acquired infections. J. Infect. Dis. 1979, 140 (5), 741–746.

   OpenUrlPubMedWeb of Science
4. 4.↵
   1. Klevens R. M.,
   2. Edwards J. R.,
   3. Richards C. L.,
   4. Horan T. C.,
   5. Gaynes R. P.,
   6. Pollock D. A.,
   7. Cardo D. M.

   Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007, 122 (2), 160–166.

   OpenUrlPubMedWeb of Science
5. 5.↵
   1. Wenzel R. P.

   1. Pittet D.

   Nosocomial Bloodstream Infections. In Prevention and Control of Nosocomial Infections, 3rd ed.; Wenzel R. P., Ed.; Lippincott Williams and Wilkins: Baltimore, MD, 1997; p 711.
6. 6.↵
   1. Klevens R. M.,
   2. Morrison M. A.,
   3. Nadle J.,
   4. Petit S.,
   5. Gershman K.,
   6. Ray S.,
   7. Harrison L. H.,
   8. Lynfield R.,
   9. Dumyati G.,
   10. Townes J. M.,
   11. Craig A. S.,
   12. Zell E. R.,
   13. Fosheim G. E.,
   14. McDougal L. K.,
   15. Carey R. B.,
   16. Fridkin S. K.

   ; Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298 (15), 1763–1771.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Cosgrove S. E.,
   2. Sakoulas G.,
   3. Perencevich E. N.,
   4. Schwaber M. J.,
   5. Karchemer A. W.,
   6. Carmeli Y.

   Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 2003, 36 (1), 53–59.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Blot S.,
   2. Vandewoude K.,
   3. Hoste E.,
   4. Colardyn F.

   Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch. Intern. Med. 2002, 162 (19), 2229–2235.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Wisplinghoff H.,
   2. Bischoff T.,
   3. Tallent S.,
   4. Seifert H.,
   5. Wenzel R.,
   6. Edmond M.

   Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 2004, 39 (3), 309–317.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Diekema D.,
    2. Pfaller M.,
    3. Jones R.

    Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America SENTRY antimicrobial surveillance program, 1997–2000. Int. J. Antimicrob. Agents 2002, 20 (6), 412–418.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Kresken M.,
    2. Hafner D.

    Drug resistance among clinical isolates of frequently encountered bacterial species in Central Europe during 1975–1995. Infection 1999, 27 (Suppl. 2), S2–8.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Eggimann P.,
    2. Sax H.,
    3. Pittet D.

    Catheter-related infections. Microbes Infect. 2004, 6 (11), 1033–1042.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Öncü S.,
    2. Sakarya S.

    ; Central venous catheter-related infections: an overview with special emphasis on diagnosis, prevention and management. The Internet Journal of Anesthesiology 2003, 7 (1).
14. 14.↵
    1. Safdar N.,
    2. Maki D. G.

    The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 2004, 30 (1), 62–67.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    Validation of moist heat sterilization processes: cycle design, development, qualification and ongoing control. PDA Technical Report 1 (revised 2007) 2006, 61 (S-1).
16. 16.↵
    1. Darouiche R. O.,
    2. Raad I. I.,
    3. Heard S. O.,
    4. Thornby J. I.,
    5. Wenker O. C.,
    6. Gabrielli A.

    A comparison of two antimicrobial-impregnated central venous catheters. N. Engl. J. Med. 1999, 340 (1), 1–8.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Tidswell E. C.

    Risk-based approaches facilitate expedient validations for control of microorganisms during equipment cleaning and hold. Am. Pharma. Rev. 2005, 8 (6), 28–33.

    OpenUrl
18. 18.↵
    1. Hillson D. A.

    Risk management: the case for including opportunity. APM Yearbook 2004/2005 2005, 3–4.
19. 19.↵
    1. Tidswell E. C.

    Risk profiling pharmaceutical manufacturing processes. Eur. J. Par. Pharma. Sci. 2004, 9 (2), 49.

    OpenUrl
20. 20.↵
    1. Tidswell E. C.

    Bacterial adhesion: considerations within a risk-based approach to cleaning validation. PDA J. Pharm. Sci. Technol. 2005, 59 (1), 10–32.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Tidswell E. C.,
    2. McGarvey B.

    Quantitative risk modeling in aseptic manufacture. PDA J. Pharm. Sci. Technol. 2006, 60 (5), 267–283.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Tidswell E. C.,
    2. McGarvey B.

    Quantitative risk modeling assists batch disposition in aseptic manufacturing. Eur. J. Par. Pharma Sci. 2007, 12 (2), 51.

    OpenUrl
23. 23.↵
    http://www.uspnf.com/uspnf/login.
24. 24.↵
    1. Lee L. D.,
    2. Berkheiser M.,
    3. Jiang Y.,
    4. Hackett B.,
    5. Hachem R. Y.,
    6. Chemaly R. F.,
    7. Raad I. I.

    Risk of bioaerosol contamination with Aspergillus species before and after cleaning in rooms filtered with high-efficiency particulate air filters that house patients with hematologic malignancy. Infect. Control Hosp. Epidemiol. 2007, 28 (9), 1066–1070.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Perdelli F.,
    2. Cristina M. L.,
    3. Sartini M.,
    4. Spagnolo A. M.,
    5. Dallera M.,
    6. Ottria G.,
    7. Lombardi R.,
    8. Grimaldi M.,
    9. Orlando P.

    Fungal contamination in hospital environments. Infect. Control Hosp. Epidemiol. 2006, 27 (1), 44–47.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Falvey D. G.,
    2. Streifel A.

    Ten-year air sample analysis of Aspergillus prevalence in a university hospital. J. Hosp. Infect. 2007, 67 (1), 35–41.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Perdelli F.,
    2. Sartini M.,
    3. Spagnolo A. M.,
    4. Dallera M.,
    5. Lombardi R.,
    6. Cristina M. L.

    A problem of hospital hygiene: The presence of Aspergilli in hospital wards with different air-conditioning features. Am. J. Infect. Control 2006, 34 (5), 264–268.

    OpenUrlPubMed
28. 28.↵
    1. Augustowska M.,
    2. Dutkiewicz J.

    Variability of airborne microflora in a hospital ward within a period of one year. Ann. Agric. Environ. Med. 2006, 13 (1), 99–106.

    OpenUrlPubMedWeb of Science
29. 29.↵
    1. Jaffal A. A.,
    2. Nsanze H.,
    3. Bener A.,
    4. Ameen A. S.,
    5. Banat I. M.,
    6. El Mogheth A. A.

    Hospital airborne microbial pollution in a desert country. Environment International 1997, 23 (2), 167–172.

    OpenUrlCrossRefWeb of Science
30. 30.↵
    1. Simon P. W.,
    2. Hillson D. A.,
    3. Newland K. E.

    Project Risk Analysis and Management (PRAM) Guide; Simon P. W., Hillson D. A., Newland K. E., Eds.; APM Group, High Wycombe, Bucks, UK, 1997.
31. 31.↵
    Risk management. Australian/New Zealand Standard AS/NZS 4360:1999; New Zealand: Standards Australia/Standards New Zealand. Homebush NSW, 1999.
32. 32.↵
    Project management—part 2: vocabulary. British Standard BS6079-2:2000; British Standards Institute, London, UK, 2000.
33. 33.↵
    A risk management standard. Institute of Risk Management, London, UK, 2002.
34. 34.↵
    1. Griffith C. J.,
    2. Obee P.,
    3. Cooper R. A.,
    4. Burton N. F.,
    5. Lewis M.

    The effectiveness of existing and modified cleaning regimens in a Welsh hospital. J. Hosp. Infect. 2007, 66 (4), 352–359.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Tidswell E. C.,
    2. Bellinger M.,
    3. McCullough D.,
    4. Allexander A.

    Consecutive replicate contact plate sampling assists investigative characterization of surface-borne bioburden. Eur. J. Parent. Pharma. Sci. 2005, 10 (4), 93–96.

    OpenUrl
36. 36.↵
    1. Schinabek M. K.,
    2. Ghannoum M. A.

    Catheter-related infections—diagnosis, treatment and infection. Clinical Microbiology Newsletter 2003, 25 (15), 113.

    OpenUrl
37. 37.↵
    1. Trissel L. A.,
    2. Gentempo J. A.,
    3. Saenz L. M.,
    4. Woodard M. Y.,
    5. Angeles C. H.

    Effect of two work practices changes on the microbial contamination rates of pharmacy-compounded sterile preparations. Am. J. Health Syst. Pharm. 2007, 64 (8), 837–841.

    OpenUrlAbstract/FREE Full Text
38. 38.↵
    1. Sherertz R. A.,
    2. Bassetti S.,
    3. Bassetti-Wyss B.

    “Cloud” health-care workers. Emerg. Infect. Dis. 2003, 7 (2), 241–244.

    OpenUrl
39. 39.↵
    1. Cooper M. S.

    Confronting models with data. J. Hosp. Infect. 2007, 55 (S2), 88.

    OpenUrl
40. 40.↵
    1. Keller S.,
    2. Marcy J.,
    3. Blakistone B.,
    4. Hackney C.,
    5. Carter W. H.

    Effect of microorganism characteristics on leak size critical to predicting package sterility. J. Food Protect. 2003, 66 (9), 1716–1719.

    OpenUrlPubMed
41. 41.↵
    1. Pasquarella C.,
    2. Pitzurra O.,
    3. Saviono A.

    The index of microbial air contamination. J. Hosp. Infect. 2000, 46 (4), 241–256.

    OpenUrlPubMed